Table 2 |
||||||
|
Arteriolar diameter, cross-sectional area, blood velocity, and arteriolar flow in norepinephrine and arginine vasopressin animals |
||||||
|
Arteriol type |
Parameter |
Drug |
Baseline |
Drug infusion |
Change (%) |
p value |
|
|
||||||
|
A0 |
Arteriolar D (μm) |
NEa |
127 ± 27 |
86 ± 16 |
31 ± 12 |
0.002b |
|
AVPa |
129 ± 7 |
66 ± 12 |
49 ± 7 |
|||
|
Arteriolar CSA (μm2) |
NEa |
13,083 ± 4,908 |
5,954 ± 2,150 |
49 ± 17 |
0.002b |
|
|
AVPa |
13,100 ± 1,462 |
3,547 ± 1,173 |
73 ± 7 |
|||
|
RBC velocity (mm/s) |
NEa |
13.5 ± 2.2 |
10.6 ± 2.3 |
22 ± 9 |
0.232 |
|
|
AVPa |
14.9 ± 0.9 |
11.2 ± 1.1 |
25 ± 6 |
|||
|
Arteriolar BF (10-2 × mm × μm2/s) |
NEa |
18.4 ± 8.1 |
6.6 ± 3.2 |
62 ± 13 |
0.004b |
|
|
AVPa |
19.6 ± 2.6 |
3.9 ± 1.3 |
80 ± 6 |
|||
|
A1 |
Arteriolar D (μm) |
NEa |
47 ± 11 |
33 ± 8 |
28 ± 12 |
0.461 |
|
AVPa |
49 ± 13 |
66 ± 12 |
30 ± 12 |
|||
|
Arteriolar CSA (μm2) |
NEa |
1,785 ± 878 |
922 ± 444 |
47 ± 16 |
0.461 |
|
|
AVPa |
2,000 ± 1,080 |
987 ± 574 |
50 ± 17 |
|||
|
RBC velocity (mm/s) |
NEa |
3.7 ± 0.7 |
3 ± 0.4 |
19 ± 9 |
0.236 |
|
|
AVPa |
3.9 ± 1 |
2.9 ± 1.2 |
27 ± 17 |
|||
|
Arteriolar BF (10-3 × mm × μm2/s) |
NEa |
6.9 ± 4.1 |
2.8 ± 1.5 |
57 ± 15 |
0.096 |
|
|
AVPa |
8.2 ± 6.2 |
2.9 ± 2.4 |
63 ± 14 |
|||
|
A2 |
Arteriolar D (μm) |
NEa |
28 ± 12 |
20 ± 9 |
29 ± 12 |
0.156 |
|
AVPa |
25 ± 8 |
16 ± 5 |
34 ± 14 |
|||
|
Arteriolar CSA (μm2) |
NEa |
748 ± 689 |
390 ± 332 |
48 ± 16 |
0.156 |
|
|
AVPa |
522 ± 345 |
226 ± 141 |
55 ± 18 |
|||
|
RBC velocity (mm/s) |
NEa |
3 ± 0.7 |
2.3 ± 0.4 |
20 ± 14 |
0.845 |
|
|
AVPa |
2.8 ± 0.4 |
2.2 ± 0.4 |
21 ± 15 |
|||
|
Arteriolar BF (10-3 × mm × μm2/s) |
NEa |
2.6 ± 3.3 |
0.9 ± 1.0 |
59 ± 13 |
0.212 |
|
|
AVPa |
1.5 ± 1.2 |
0.5 ± 0.4 |
64 ± 19 |
|||
|
A3 |
Arteriolar D (μm) |
NEa |
15 ± 6 |
10 ± 5 |
34 ± 11 |
0.110 |
|
AVPa |
16 ± 5 |
9 ± 3 |
43 ± 12 |
|||
|
Arteriolar CSA (μm2) |
NEa |
193 ± 180 |
86 ± 96 |
56 ± 14 |
0.110 |
|
|
AVPa |
86 ± 96 |
74 ± 51 |
86 ± 13 |
|||
|
RBC velocity (mm/s) |
NEa |
2.3 ± 0.4 |
1.8 ± 0.4 |
21 ± 16 |
0.146 |
|
|
AVPa |
2.4 ± 0.4 |
1.7 ± 0.6 |
29 ± 16 |
|||
|
Arteriolar BF (10-4 × mm × μm2/s) |
NEa |
4.7 ± 4.9 |
1.6 ± 1.6 |
65 ± 12 |
0.013 |
|
|
AVPa |
5.6 ± 4.9 |
1.3 ± 1.3 |
76 ± 11 |
|||
|
A4 |
Arteriolar D (μm) |
NEa |
9 ± 3 |
6 ± 1 |
32 ± 8 |
0.206 |
|
AVPa |
9 ± 2 |
7 ± 2 |
26 ± 12 |
|||
|
Arteriolar CSA (μm2) |
NEa |
70 ± 62 |
28 ± 14 |
53 ± 10 |
0.206 |
|
|
AVPa |
74 ± 41 |
39 ± 20 |
44 ± 18 |
|||
|
RBC velocity (mm/s) |
NEa |
1.7 ± 0.3 |
1.3 ± 0.3 |
21 ± 14 |
0.464 |
|
|
AVPa |
1.5 ± 0.3 |
1.1 ± 0.1 |
27 ± 19 |
|||
|
Arteriolar BF (10-4 × mm × μm2/s) |
NEa |
1.3 ± 1.4 |
0.4 ± 0.3 |
63 ± 10 |
0.837 |
|
|
AVPa |
1.2 ± 0.9 |
0.5 ± 0.3 |
57 ± 21 |
|||
|
|
||||||
|
Data are given as mean values ± standard deviation. aSignificant difference between baseline and drug infusion. bSignificant difference of change (%) between arginine vasopressin (AVP) and norepinephrine (NE) animals. BF, blood flow; CSA, cross-sectional area; D, diameter; RBC, red blood cell. |
||||||
|
Friesenecker et al. Critical Care 2006 10:R75 doi:10.1186/cc4922 |
||||||